Back to search

Denmark· DK-28106873322

Chininsulfat "Axunio"

A quinine and derivatives product containing quininsulfatdihydrat, registered in Denmark by axunio Pharma GmbH.

ATC M09AA

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedChininsulfat "Axunio"ATCM09AAREGISTER NO.DK-28106873322PACKS LISTED1CHECKEDSeptember 30, 2026

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
Quininsulfatdihydrat
Manufacturer
axunio Pharma GmbH
Country
Denmark (DK)
ATC code
M09AA
ATC class
Quinine and derivatives
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28106873322

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d5e9b779-96ee-4eb6-bc07-e0a5bf1ee7ae
GET /v1/drugs/d5e9b779-96ee-4eb6-bc07-e0a5bf1ee7ae?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "filmovertrukne tabletter",
  "source": "dkma",
  "strength": "200 mg",
  "auth_role": "CMS",
  "dk_drugid": "28106873322",
  "substance": "Quininsulfatdihydrat",
  "auth_procedure": "Decentral procedure",
  "in_medicinpriser": true,
  "registration_date_serial": "45546"
}

See everything about quininsulfatdihydrat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.